Author

Jyothilakshmi Sajimon

Centre For Human GeneticsORCID 0009-0008-0336-3516Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Archana P Thankamony· 1 shared Athulya Prakash Simla· 1 shared Debolina Das· 1 shared Diya Aich· 1 shared Gayatri KandpaliD· 1 shared Jyothi S. PrabhuiD· 1 shared Kavitha Modenkattil Sethumadhavan· 1 shared Manju Moorthy· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Archana P Thankamony

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyMethodsPeer-reviewedApr 21, 2026

A Versatile, Simple, and Rapid (VSR) method for generating gene clones, diverse mutants, and short gene fragments for molecular biology applications

Kavitha Modenkattil Sethumadhavan, Gayatri Kandpal, Jyothilakshmi Sajimon…·Victor Stalin Raj

The paper introduces a VSR method that enables gene cloning, mutagenesis, and short gene synthesis in a single reaction with high efficiency and flexibility.

DOI 10.1016/j.ymeth.2026.04.005

experimental assay

𝕏 PostBluesky

Cancer BiologyAdvances in Cancer Biology - MetastasisPeer-reviewedNov 27, 2025

Repurposing statins in combination therapy for effective ablation of metastatic breast cancer

Rifat Aara, Neeha Sinai Borker, Jyothilakshmi Sajimon…·Radhika Nair

This study evaluates lovastatin's efficacy in combination with chemotherapy to ablate chemoresistant metastatic breast cancer cells by targeting Macc1 overexpression.

DOI 10.1016/j.adcanc.2025.100166

humanbulk RNA-seq

𝕏 PostBluesky